I haven't come across a successful CEO who grabs millions in compensation before seeing a penny in profit, and to manage a company with a staff of barely 40, puts a lot of useful innovative scientific staff on the street, screws up important trials and forces the FDA to impose 8-month long complete hold, and sells off valuable assets dirt cheap!!
How long have you Ben following this stock and closely reviewing what and why happened in the past? You seem to be a novice without much deeper understanding.
Scarlett keeps wrecking it!! Is it time to get rid of him and his cronies and get someone much less greedy and has better business sense? What do you think?
Rokky, your Point 1 is a pure conjecture and is not credible. Regarding your Point 2, the situation at Geron is far different due to the impending acquisition and, hence, suspected dilution,and apparently WS's lack of confidence in the Geron management (which sold the stem-cell assets dirt cheap while placing the spinal-cord trial on the shelf which is now activated by Asteria and is getting good reviews, and which brought about the 8-month long complete hold due to the LFT screw up). I am sure the other company you are talking about had no such deterrents.
Those are the shares the bozos at Geron gave away free to WS crooks during the last offering, deliberately set up to fool the bozos. These shares, I am sure, are now in the hands of hedge funds those WS crooks manage. The other impediment to the SP stabilization is the premature announcement by Scarlett, an idiot in the eyes of WS guys, of the acquisition which the WS gurus think will require another offering and which the bozos at Geron may not be able to handle well. Scarlrtt's greed to squeeze hefty compensation even before the Janssen trials began is another sign that he believes in filling his pocket before shareholders'. These are the real reasons for the dismal SP action and, I do not believe, the trial results will make a significant improvement. Building unreal expectation based on announcement of the interim results will simply hurt you and none else!!
Freddy, how true what you just quoted in the name of Larry Smith!! I have to agree whole-heartedly. However, I have always wondered if this is known to the SEC guys or not and, if known to them, why there is no attempt by them to stop it instead of catching just the insider of fences!! Furthermore, why the CFO's of the affected biotechs do not do anything to stop such manipulation of their company stocks?! This certainly is indicative of deeply rooted corruption in the securities trading business and why politicians shy away to stop it.
Anne, do not forget that IMET is targeting primarily hematologic cancers, not solid tumor cancers. It may help in case of solid tumors but that is not yet in hand. Keytruda apparently is good for solid tumors and works quite differently than IMET and, I believe, is primarily to improve immune response of the body and not for curing cancers. Therefore, your implied comparison is not appropriate.
You have understood it right. However, most on this board can't comprehend due to their lack of knowledge and even common sense. Retail traders (I call them Mon.....keys) do not have much of the brain and, hence, useless to discuss anything intelligent with them!!!.
Good and honest statement. Rare on this board!! You have a credible assessment. Thanks for the sincerity to let others know what your thoughts are.
Yes, that's what exactly is going on: Sale On News, whether the news are good or bad. In this case, the news is not bad, just a routine business need for a company that wants to grow its business. But, the mon'''key traders always hop in and out!!!
The loan is intended to help growing business!! This is done by many companies that do not have enough cash to engage in this activity!! Have you run a business yourself?
Apparently not!! Simply, it helps get more contracts by facilitating financing for customers. The posts by idiots on this board questioning the need simply show the posters' ignorance or naivety w.r.t. business needs.
Don, the fact of the matter is that despite excellent financial and asset condition, the SP has dropped fro a reasonable level of $5+ to half that much!! The only reason I can think of for that is that WS doesn't have confidence in these bozos to find a real gem for acquisition and, if they do, to handle it!! The IMET glory is brought single-handedly by Tefferi first and that the Mayo work alone could have convinced Janssen to plunge into IMET's future. Do you think these bozos who are after million dollar compensation could have done that without Tefferi and Janssen (which got the ODD for IMET so fast?!!! To me, they haven't yet proven themselves worthy of any shareholder praise!!!